The V Foundation Announces Multi-Million Dollar Challenge to Further the Study of BRCA Mutation Research

Wednesday, November 30, 2016 Research News
Email Print This Page Comment bookmark
Font : A-A+

BRCA Foundation and the Gray Foundation Commit to Support BRCA Research Collaborative Grants

CARY, N.C., Nov. 30, 2016 /PRNewswire/ -- The V Foundation for Cancer Research, one of the nation's leading funders of

cancer research, is pleased to announce a new partnership with the San Francisco-based BRCA Foundation and the Gray Foundation to fund research of cancers that derive from BRCA or BRCA-like mutations.  Each organization will provide a $1.5 million challenge to the V Foundation for BRCA Research Collaborative Grants. This research will advance the study of inherited mutations in BRCA1 and BRCA2, genes that produce tumor suppressor proteins.  Women and men born with a mutated copy of either BRCA1 or BRCA2 are at a significantly increased risk of developing cancer.  With a successful match to the challenge, the combined investment for this cutting-edge research will be $6 million.

"Working together to beat BRCA cancer is at the heart of our mission. The partnership with the V Foundation and the Basser Initiative at the Gray Foundation creates a powerhouse that allows us to take the BRCA cancer research to the next level," said Evan Goldberg, Founder of Oracle NetSuite and Chairman, President and Director of BRCA Foundation. "I look forward to joining forces to make our joint initiatives successful."

A member of the V Foundation's Board of Directors, Goldberg launched the BRCA Foundation in early 2016 to bring about new therapies, cures and preventative treatments for those carrying hereditary BRCA gene mutations. Goldberg, who was adopted shortly after birth, learned he carries the mutation after his birth mother contacted him following her positive genetic test and second bout of breast cancer. His adoptive and biological parents are both of Ashkenazi Jewish descent, one of the ethnic and geographic groups with a much higher prevalence of harmful BRCA1 and BRCA2 mutations.   

"Research focused on the BRCA1 and 2 genes encompasses cutting-edge aspects of clinical, translational and basic research, including germline and tumor genetic testing, new approaches to early detection and prevention, circulating tumor DNA, novel therapeutics targeting DNA repair and many others," said James M. Ford, M.D., member of the V Foundation's Scientific Advisory Committee and Professor of Medicine/Oncology and Genetics at the Stanford School of Medicine.  "This challenge gift will fund substantial and exciting new approaches to helping carriers of these cancer susceptibility genes, as well as many other cancer patients."

Initial studies focused on breast and ovarian cancer, but research shows the BRCA1 and BRCA2 genes function at multiple sites throughout the body.  For example, there is a significant increased risk of pancreatic cancer, male breast cancer and prostate cancer, particularly in individuals with BRCA2 mutations.  Patients with BRCA1 and BRCA2 alterations are also predisposed to developing cancer at a younger age than those without the mutations. Research has also found men with BRCA1 or BRCA2 mutations have higher rates of breast, prostate or pancreatic cancer. 

"We are thrilled to be raising both awareness and new funding to support BRCA research," said Mindy Gray, Co-Founder of the Gray Foundation.  "Jon and I are excited to partner with the BRCA Foundation and the V Foundation to break down barriers, enhance collaborations and ultimately envision a world that gives better options to the generations of families who face the decisions that come with having a BRCA mutation."

Mindy and Jon Gray established the Basser Center for BRCA at the University of Pennsylvania's Abramson Cancer Center in 2012. The Basser Center was named in honor of Faith Basser, Mindy's sister who died of ovarian cancer at the age of 44.  It was the first center in the world dedicated to the treatment, prevention and cure of BRCA-related cancers.  The Grays have given more than $30 million to the Basser Center and additionally fund research at a number of other leading cancer centers.

The V Foundation's Wine Celebration, an annual signature fundraising event held in Napa Valley, California, will feature BRCA research at the 2017 event's "Fund-A-Need," ensuring no less than $6 million will be awarded to accelerate such research.  A subset of the V Foundation's Scientific Advisory Committee, along with world-renown experts, including Dr. Susan Domchek from the Basser Center for BRCA at the Abramson Cancer Center and Dr. Alan Ashworth from University of California San Francisco, will select grants for the best BRCA mutation projects at institutions nationwide. 

For more information about the V Foundation for Cancer Research or to make a donation, please visit 

About the V Foundation for Cancer ResearchThe V Foundation for Cancer Research is dedicated to declaring victory over cancer. It was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State basketball coach and ESPN commentator. Since 1993, the Foundation has funded more than $170 million in cancer research grants nationwide. It awards 100 percent of all direct cash donations to cancer research and related programs. Due to generous donors, the Foundation has an endowment that covers administrative expenses.  The Foundation awards peer-reviewed grants through a competitive awards process vetted by a Scientific Advisory Committee.  For more information on The V Foundation, please visit

About BRCA FoundationThe BRCA Foundation's mission is to accelerate research and foster collaboration to cure and prevent BRCA cancers. We invest in the most promising work of top scientific investigators, while creating a forum for successful partnerships across institutions, all with the goal of getting the fastest possible results. Launched in early 2016 by Oracle Netsuite founder Evan Goldberg and his wife, Cindy, the aim of the Foundation is to create a world free of the threat of BRCA cancers. For more, visit, follow us on Twitter or like us on Facebook.

About the Gray FoundationThe Gray Foundation was founded in 2014 by Jon and Mindy Gray.  The Gray Foundation is focused on funding initiatives to advance the care of individuals living with BRCA gene mutations.  In addition to founding the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, and providing over $30M in funding to the Center, the Gray Foundation also supports a number of leading medical institutions including Memorial Sloan Kettering, Weill Cornell, Johns Hopkins and others.  The Gray Foundation also commits significant resources to maximize access to education, healthcare and opportunity for low-income children in New York.

To view the original version on PR Newswire, visit:

SOURCE BRCA Foundation


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store